Iq Eq Fund Management (Ireland) LTD Nurix Therapeutics, Inc. Transaction History
Iq Eq Fund Management (Ireland) LTD
- $1.09 Billion
- Q2 2025
A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 26,406 shares of NRIX stock, worth $263,531. This represents 0.03% of its overall portfolio holdings.
Number of Shares
26,406
Previous 14,249
85.32%
Holding current value
$263,531
Previous $169,000
77.51%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding NRIX
# of Institutions
174Shares Held
79.3MCall Options Held
126KPut Options Held
11.3K-
Black Rock Inc. New York, NY6.82MShares$68.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.06MShares$60.5 Million2.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$44.6 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.95MShares$39.4 Million4.19% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$38.7 Million0.45% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $471M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...